Skip to Main Content

Paper Details

Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co-Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer.
1
2023
4-OH-tamoxifen, Breast Cancer, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP2D6 diplotype, CYP2D6*17, CYP2D6*17 and *29, CYP2D6*29, CYP3A4, CYP3A5, ENDO, GenoPharm open array, N-desmethyltamoxifen, NDM, TAM, Tamoxifen, Women, breast cancer, endoxifen, hormone-receptor positive breast cancer, patients, people, plasma, tamoxifen
Author NameAffiliation
Alfred I NeugutVagelos College of Physicians and Surgeons, Columbia University
Alfred I NeugutHerbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University
Alfred I NeugutMailman School of Public Health, Columbia University
Judith S JacobsonHerbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University
Judith S JacobsonMailman School of Public Health, Columbia University
  • 1 - 5

Datasets

Release 1.2